Evidence map›Paper›PMID 31533830›Full record

ArticleSkeletal muscle2019

Defective angiogenesis in CXCL12 mutant mice impairs skeletal muscle regeneration.

David Hardy, Mylène Fefeu, Aurore Besnard, David Briand, Paméla Gasse, Fernando Arenzana-Seisdedos, Pierre Rocheteau, Fabrice Chrétien

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Spatiotemporal dynamics of fetal liver hematopoietic niches.The Journal of experimental medicine · 2025
    Article
  3. Article
  4. A Novel tRNA-Derived Fragment, tRFInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Autophagy in muscle regeneration: potential therapies for myopathies.Journal of cachexia, sarcopenia and muscle · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

David HardyExperimental Neuropathology Unit, Institut Pasteur, 75015, Paris, France.
Mylène FefeuExperimental Neuropathology Unit, Institut Pasteur, 75015, Paris, France.
Aurore BesnardExperimental Neuropathology Unit, Institut Pasteur, 75015, Paris, France.
David BriandExperimental Neuropathology Unit, Institut Pasteur, 75015, Paris, France.
Paméla GasseViral Pathogenesis Unit, Institut Pasteur, 75015, Paris, France.
Fernando Arenzana-SeisdedosViral Pathogenesis Unit, Institut Pasteur, 75015, Paris, France.
Pierre RocheteauExperimental Neuropathology Unit, Institut Pasteur, 75015, Paris, France.
Fabrice ChrétienExperimental Neuropathology Unit, Institut Pasteur, 75015, Paris, France. Fabrice.chretien@pasteur.fr.ORCID 0000-0001-5874-4377
Institut Pasteur · FRDélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring muscle regeneration, the chemokine CXCL12 (SDF-1) and the synthesis of some specific heparan sulfates (HS) have been shown to be critical. CXCL12 activity has been shown to be heavily influenced by its binding to extracellular glycosaminoglycans (GAG) by modulating its presentation to its receptors and by generating haptotactic gradients. Although CXCL12 has been implicated in several phases of tissue repair, the influence of GAG binding under HS influencing conditions such as acute tissue destruction remains understudied.

methodsTo investigate the role of the CXCL12/HS proteoglycan interactions in the pathophysiology of muscle regeneration, we performed two models of muscle injuries (notexin and freeze injury) in mutant CXCL12

resultsWe showed that despite normal histology of the resting muscle and normal muscle stem cell behavior in the mutant mice, endothelial cells displayed an increase in the angiogenic response in resting muscle despite the downregulated transcriptomic changes induced by the CXCL12 mutation. The regenerative capacity of the CXCL12-mutated mice was only delayed after a notexin injury, but a severe damage by freeze injury revealed a persistent defect in the muscle regeneration of CXCL12 mutant mice associated with vascular defect and fibroadipose deposition with persistent immune cell infiltration.

conclusionThe present study shows that CXCL12 is crucial for proper muscle regeneration. We highlight that this homing molecule could play an important role in drastic muscle injuries and that the regeneration defect could be due to an impairment of angiogenesis, associated with a long-lasting fibro-adipogenic scar.

Indexed as

AnimalsChemokine CXCL12Elapid VenomsEndothelial CellsFreezingGene Expression ProfilingHeparan Sulfate ProteoglycansMaleMiceMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicMuscle, SkeletalNeovascularization, PhysiologicRegenerationSatellite Cells, Skeletal MuscleChemokine CXCL12Cxcl12 protein, mouseElapid VenomsHeparan Sulfate ProteoglycansnotexinAngiogenesisCXCL12Endothelial cellsFibrosisHeparan sulfatesMuscle stem cellsRegenerationSkeletal muscleVasculogenesis

Identifiers

PMID31533830
PMCPMC6751827
OpenAlexW2973542234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.